Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Amble vs Lyfe Rx

Amble
Graded #212

Higher grade

vs+7.5
Lyfe Rx
Graded #375

Lower grade

The verdict

Amble takes it — 65.8/100 to 58.3/100.

Amble grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth weight loss provider offering compounded semaglutide and tiered tirzepatide programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAmble +11
61
50
Dose & formulationEven
64
64
Clinical oversightAmble +12
79
67
Labs & monitoringEven
52
52
FulfillmentAmble +19
81
62
Contract termsEven
55
55
Amble · left barLyfe Rx · right bar

The numbers

MetricAmbleLyfe Rx
WeighScore65.8/10058.3/100
GradeCC
Scorecard rank#212#375
Semaglutide$179/mo (starting dose, compounded)$225/mo (compounded)
Tirzepatide$289/mo (starting dose, compounded)$299/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Amble

Graded #212 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Lyfe Rx

Graded #375 · C

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Delivery to all 50 states with 1–3 day pharmacy turnaround

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • Also sells non-prescription supplements ('Tirzepatide Weight Loss Supplement', 'Lipo Burn')
  • Shopify-based e-commerce storefront — less clinical infrastructure
  • FDA issued this company a warning letter dated 9 September 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard